398
Participants
Start Date
February 2, 2015
Primary Completion Date
November 18, 2019
Study Completion Date
November 18, 2019
Cemiplimab
Hypofractionated radiotherapy
Cyclophosphamide
Docetaxel
Carboplatin
GM-CSF
Paclitaxel
Pemetrexed
University of Pittsburgh Medical Center Shadyside, Pittsburgh
The Angeles Clinic and Research Institute, Los Angeles
Banner MD Anderson Cancer Center, Gilbert
Western Regional Medical Center, Goodyear
Mayo Clinic, Phoenix
University of Arizona Cancer Center, Tucson
City of Hope National Medical Center, Duarte
Ronald Reagan UCLA Medical Center, Los Angeles
Stanford University, Stanford
Sarah Cannon Research Institute at HealthONE, Denver
Norwalk Hospital, Norwalk
Georgetown University Medical Center, Washington D.C.
H Lee Moffitt Cancer Center and Research Institute, Tampa
Winship Cancer Institute, Emory University, Atlanta
University of Chicago, Chicago
Indiana University, Indianapolis
University of Kansas Cancer Center, Fairway
Dana Farber Cancer Institute, Boston
Barbara Ann Karmanos Cancer Center, Detroit
Washington University School of Medicine Siteman Cancer Center, St Louis
Nebraska Methodist Hospital, Omaha
Hackensack University Medical Center, Hackensack
Cancer Institute of New Jersey, New Brunswick
Columbia University Medical Center, New York
Laura & Isaac Perlmutter Cancer Center, New York
Mount Sinai Medical Center, New York
Weill Cornell Medical College, New York
Duke Cancer Institute, Durham
University Hospitals Case Medical Center, Cleveland
Stephenson Cancer Center, Oklahoma City
Providence Portland Medical Center, Portland
Penn State Milton S Hershey Medical Center, Hershey
Miriam Hospital, Providence
Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville
Mary Crowley Cancer Research Center - Medical City, Dallas
Baylor College of Medicine, Houston
The University of Texas MD Anderson Cancer Center, Houston
START South Texas Accelerated Research Therapeutics, San Antonio
Northwest Medical Specialties, Tacoma
Peter Maccallum Cancer Centre, Melbourne
Institut Catala d'Oncologia L'hospitalet, L'Hospitalet de Llobregat
Hospital Universitario Vall d'Hebron, Barcelona
Fundacion Jimenez Diaz, Madrid
Hospital Universitario HM Sanchinarro-CIOCC, Madrid
Hospital Universitario Ramon y Cajal, Madrid
MD Anderson Cancer Center, Madrid
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY